Belite Bio Statistics
Total Valuation
Belite Bio has a market cap or net worth of $6.31 billion. The enterprise value is $5.82 billion.
| Market Cap | 6.31B |
| Enterprise Value | 5.82B |
Important Dates
The last earnings date was Wednesday, August 12, 2026, after market close.
| Earnings Date | Aug 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Belite Bio has 40.27 million shares outstanding. The number of shares has increased by 17.91% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 40.27M |
| Shares Change (YoY) | +17.91% |
| Shares Change (QoQ) | +0.79% |
| Owned by Insiders (%) | 1.78% |
| Owned by Institutions (%) | 16.34% |
| Float | 19.38M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 43.75 |
| PB Ratio | 8.13 |
| P/TBV Ratio | 8.13 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 33.56
| Current Ratio | 33.56 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -59,343.00 |
Financial Efficiency
Return on equity (ROE) is -22.10% and return on invested capital (ROIC) is -16.01%.
| Return on Equity (ROE) | -22.10% |
| Return on Assets (ROA) | -15.65% |
| Return on Invested Capital (ROIC) | -16.01% |
| Return on Capital Employed (ROCE) | -15.28% |
| Weighted Average Cost of Capital (WACC) | -2.49% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.50M |
| Employee Count | 41 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Belite Bio has paid $55,000 in taxes.
| Income Tax | 55,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +146.29% in the last 52 weeks. The beta is -1.22, so Belite Bio's price volatility has been lower than the market average.
| Beta (5Y) | -1.22 |
| 52-Week Price Change | +146.29% |
| 50-Day Moving Average | 155.80 |
| 200-Day Moving Average | 156.12 |
| Relative Strength Index (RSI) | 46.14 |
| Average Volume (20 Days) | 173,608 |
Short Selling Information
The latest short interest is 1.12 million, so 5.32% of the outstanding shares have been sold short.
| Short Interest | 1.12M |
| Short Previous Month | 1.13M |
| Short % of Shares Out | 5.32% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 6.37 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -118.69M |
| Pretax Income | -102.31M |
| Net Income | -102.36M |
| EBITDA | -118.49M |
| EBIT | -118.69M |
| Earnings Per Share (EPS) | -$2.74 |
Balance Sheet
| Cash & Cash Equivalents | n/a |
| Total Debt | n/a |
| Net Cash | n/a |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 776.64M |
| Book Value Per Share | 19.28 |
| Working Capital | 486.65M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | -178,000 |
| Depreciation & Amortization | 192,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -37.17M |
| FCF Per Share | -$0.92 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Belite Bio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -17.91% |
| Shareholder Yield | -17.91% |
| Earnings Yield | -1.62% |
| FCF Yield | -0.59% |
Analyst Forecast
The average price target for Belite Bio is $214.00, which is 36.58% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $214.00 |
| Price Target Difference | 36.58% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |